Shaher Altoumah

Shaher Altoumah practices at Loma Linda University Medical Center in Loma Linda, California, part of Seventh-day Adventist Church.

Shaher Altoumah's NPI, 1962976712, was assigned on January 15, 2019. Shaher Altoumah holds California license PA56689.

Shaher Altoumah's primary practice is Loma Linda University Medical Center, at 11234 Anderson St, Loma Linda, CA 92354 in San Bernardino County. The practice phone is (909) 558-4000.

Shaher Altoumah's primary practice is Loma Linda University Medical Center in Loma Linda, California, part of Seventh-day Adventist Church. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG).

Dmand AI tracks the electronic health record (EHR) system at each site where Shaher Altoumah practices. Vendor and product names are available with a free account.

Physician assistant is Shaher Altoumah's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Shaher Altoumah is board certified in 2019 - 2021 by the CA State PA License. Shaher Altoumah is licensed in California.

Dmand AI lists acute skin infection, chronic obstructive pulmonary disease (COPD), ear infection, gastroenteritis, lower back pain, muscle pain, fibromyalgia, and limb pain, muscle weakness and pneumonia among the conditions Shaher Altoumah treats.

CMS data shows 130 Medicare services from Shaher Altoumah across 4 procedure codes in 2024, for 127 Medicare patients. Medicare paid $9,184 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 127 Medicare patients who saw Shaher Altoumah in 2024. The largest group is 65 to 74, with 58 patients. 75% of them have high blood pressure, and 64% have high cholesterol. 53% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Shaher Altoumah's median patient age at 44, with 64% women.

In 2024, Shaher Altoumah wrote 2,975 Medicare Part D claims for 514 patients. 83% of them were for generic drugs. CMS names the drug for 2,310 of them, across 59 drugs with 11 or more claims each, at $242,741 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Shaher Altoumah for performance year 2024, reported as part of a group. Shaher Altoumah accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 48 general payments to Shaher Altoumah from 14 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $471.